These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 16204076)
1. Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function. Escuin D; Kline ER; Giannakakou P Cancer Res; 2005 Oct; 65(19):9021-8. PubMed ID: 16204076 [TBL] [Abstract][Full Text] [Related]
2. Microtubules regulate hypoxia-inducible factor-1α protein trafficking and activity: implications for taxane therapy. Carbonaro M; Escuin D; O'Brate A; Thadani-Mulero M; Giannakakou P J Biol Chem; 2012 Apr; 287(15):11859-69. PubMed ID: 22367210 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide. Gertsch J; Meier S; Müller M; Altmann KH Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273 [TBL] [Abstract][Full Text] [Related]
4. A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel. Dabydeen DA; Florence GJ; Paterson I; Hamel E Cancer Chemother Pharmacol; 2004 May; 53(5):397-403. PubMed ID: 15060743 [TBL] [Abstract][Full Text] [Related]
5. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation. Honore S; Kamath K; Braguer D; Wilson L; Briand C; Jordan MA Mol Cancer Ther; 2003 Dec; 2(12):1303-11. PubMed ID: 14707271 [TBL] [Abstract][Full Text] [Related]
6. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Chen JG; Horwitz SB Cancer Res; 2002 Apr; 62(7):1935-8. PubMed ID: 11929805 [TBL] [Abstract][Full Text] [Related]
7. Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein. Jung YJ; Isaacs JS; Lee S; Trepel J; Neckers L J Biol Chem; 2003 Feb; 278(9):7445-52. PubMed ID: 12488445 [TBL] [Abstract][Full Text] [Related]
8. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach. Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341 [TBL] [Abstract][Full Text] [Related]
9. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. Thomas SL; Zhong D; Zhou W; Malik S; Liotta D; Snyder JP; Hamel E; Giannakakou P Cell Cycle; 2008 Aug; 7(15):2409-17. PubMed ID: 18682687 [TBL] [Abstract][Full Text] [Related]
10. Strategies for the development of novel Taxol-like agents. Mooberry SL Methods Mol Med; 2007; 137():289-302. PubMed ID: 18085237 [TBL] [Abstract][Full Text] [Related]
11. Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells. Shahabi S; Yang CP; Goldberg GL; Horwitz SB Gynecol Oncol; 2010 Nov; 119(2):345-50. PubMed ID: 20674962 [TBL] [Abstract][Full Text] [Related]
12. Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells. Bröker LE; Huisman C; Ferreira CG; Rodriguez JA; Kruyt FA; Giaccone G Cancer Res; 2002 Jul; 62(14):4081-8. PubMed ID: 12124345 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents. Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019 [TBL] [Abstract][Full Text] [Related]
14. M410, a combretastatin A4 analogue, disrupts microtubules and inhibits HIF-1α in human breast cancer cells. Yang H; Xia Q; Zou Y; Wang K; Jiang W; Cai Y Oncol Rep; 2015 Jul; 34(1):334-40. PubMed ID: 25976207 [TBL] [Abstract][Full Text] [Related]
15. Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Bergstralh DT; Ting JP Cancer Treat Rev; 2006 May; 32(3):166-79. PubMed ID: 16527420 [TBL] [Abstract][Full Text] [Related]
16. Role of vincristine in the inhibition of angiogenesis in glioblastoma. Park KJ; Yu MO; Park DH; Park JY; Chung YG; Kang SH Neurol Res; 2016 Oct; 38(10):871-9. PubMed ID: 27472259 [TBL] [Abstract][Full Text] [Related]
17. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923 [TBL] [Abstract][Full Text] [Related]
18. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest. Kamath K; Jordan MA Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931 [TBL] [Abstract][Full Text] [Related]
19. Microtubular stability affects cardiomyocyte glycolysis by HIF-1alpha expression and endonuclear aggregation during early stages of hypoxia. Teng M; Dang YM; Zhang JP; Zhang Q; Fang YD; Ren J; Huang YS Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1919-31. PubMed ID: 20228255 [TBL] [Abstract][Full Text] [Related]